UPM Pharmaceuticals

UPM Pharmaceuticals is an award winning, contract development and manufacturing organization (CDMO) with a rich pedigree in late-stage commercial manufacturing of semi-solid and oral solid dose.

Large-Scale Pharmaceutical Manufacturer
We are an award-winning CDMO pharmaceutical development company. We specialize in everything from commercial manufacturing to quality and regulatory support — and all forms of pharmaceutical-grade manufacturing.

Our team's track record for quality and on-time performance will help you reach commercial success. We offer cross-functional collaboration and end-to-end supply chain management paired with customer service that is unmatched in the industry. From supplier management to data collection and post-marketing surveillance, we are the pharmaceutical development service partner you can rely on.

Operating out of a 475,000-square-foot, large-scale cGMP and FDA-guided manufacturing facility in Bristol, Tennessee, UPM combines the robust track record of a large pharmaceutical supplier with the agility of an independent, family-owned US-based CDMO. For our customers, this translates to exceptional quality and reliability — and a level of personalized service not often seen in a large pharma company in the US.

Beyond our expertise and technology, UPM is a contract manufacturing organization that has a passion for propelling our customers’ journeys to market, even when the journey doesn’t begin with us. As a large-scale CDMO, technology transfer and scale-up are our specialties; we welcome the opportunity to sit down with you to create a pharma solution by understanding the evolution of your project, your commercial goals, and how we can work together to get your product across the finish line.

Pharmaceutical Manufacturing Process
We offer all aspects of pharma commercial operations, including manufacturing, packaging and storage of semi-solid creams and ointments, We are proud to be an established pharma outsourcing supplier for many well-known brand name and generic products., DEA Schedule I–V controlled substances, solid tablets and capsules. Our high-volume pharmaceutical manufacturing process has the ability to produce hundreds of millions of doses annually.